COVID-19 has led to a wave of new rules and a new set of expectations involving clinical trials as research centers such as UT Southwestern modified their clinical trials operations. With patient safety always front and center, the process had to be streamlined to deal with a new reality of constraint—for example, patients couldn’t travel so research needed to go virtual. This means that centers such as UT Southwestern had to utilize remote consents, telehealth and move generally from a site-intensive to patient-centric experience. UTSW recently completed a survey of clinical research professionals about all of these changes. The overwhelming response has been positive: clinical trial coordinators, managers and nurses like the changes and a majority don’t want to go back to the past but stay with the future.
Wisdom from Harold C. Simmons Comprehensive Cancer Center
The events of the last several months represent unprecedented change reported David Gerber, MD, professor of internal medicine at UTSW and first author of an article reporting on the survey results. This paper was published in the Journal of the National Comprehensive Cancer Network. Dr. Gerber, a...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).